Recently, HER2 expression and ERRB2 amplification were assessed in a group of aggressive salivary duct carcinomas and the HER2 score was considered promising to direct HER2-specfic therapies [9]. The gene discussed is ERBB2; the disease is salivary duct carcinoma.